GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors.

Investor logo

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors

ŠEDA Václav HOFERKOVÁ Eva ONDRIŠOVÁ Laura KOŠŤÁLOVÁ Lenka SHARMA Sonali LOJA Tomáš ZICHA Daniel VERNER Jan POSPÍŠILOVÁ Šárka BRYCHTOVÁ Yvona PANOVSKÁ Anna DOUBEK Michael MAYER Jiří MRÁZ Marek

Year of publication 2021
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology

Citation
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info